Suppression of Gluconeogenic Gene Expression by LSD1-Mediated Histone Demethylation

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Pan, Dongning ^a   Mao, Chunxiao ^a   Wang, Yong Xu ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSE BISPHOSPHATASE; GLUCOSE 6 PHOSPHATASE; HISTONE H3; LYSINE; MESSENGER RNA; REGULATOR PROTEIN; DNA BINDING PROTEIN; DNA HELICASE; FUBP1 PROTEIN, HUMAN; GLUCOSE; HISTONE; HISTONE DEMETHYLASE; KDM1A PROTEIN, HUMAN; TRANYLCYPROMINE;

ANIMAL CELL; ARTICLE; CELL STRAIN HEPG2; EPIGENETICS; FRUCTOSE 1,6 BISPHOSPHATASE 1 GENE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; GLUCONEOGENESIS; GLUCOSE 6 PHOSPHATASE GENE; GLYCOGEN ANALYSIS; HISTONE DEMETHYLATION; HISTONE MODIFICATION; HUMAN; HUMAN CELL; LIVER CELL CULTURE; LYSINE SPECIFIC DEMETHYLASE 1A GENE; MOUSE; NONHUMAN; PRIMARY CELL CULTURE; PROMOTER REGION; REGULATOR GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; ANTAGONISTS AND INHIBITORS; GENE EXPRESSION; GENETIC EPIGENESIS; GENETICS; HEPG2 CELL LINE; METABOLISM; METHYLATION; PROTEIN PROCESSING;

DNA HELICASES; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GLUCONEOGENESIS; GLUCOSE; GLUCOSE-6-PHOSPHATASE; HEP G2 CELLS; HISTONE DEMETHYLASES; HISTONES; HUMANS; METHYLATION; PROMOTER REGIONS, GENETIC; PROTEIN PROCESSING, POST-TRANSLATIONAL; TRANSCRIPTIONAL ACTIVATION; TRANYLCYPROMINE;

EID: 84878756235     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066294     Document Type: Article

References (42)

1. Magnusson I, Rothman DL, Katz LD, Shulman RG, Shulman GI, (1992) Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J Clin Invest 90: 1323-1327.
2. Wajngot A, Chandramouli V, Schumann WC, Ekberg K, Jones PK, et al. (2001) Quantitative contributions of gluconeogenesis to glucose production during fasting in type 2 diabetes mellitus. Metabolism 50: 47-52.
3. Kunert O, Stingl H, Rosian E, Krssak M, Bernroider E, et al. (2003) Measurement of fractional whole-body gluconeogenesis in humans from blood samples using 2H nuclear magnetic resonance spectroscopy. Diabetes 52: 2475-2482.
4. Chou JY, Jun HS, Mansfield BC, (2010) Glycogen storage disease type I and G6Pase-beta deficiency: etiology and therapy. Nat Rev Endocrinol 6: 676-688.
5. Wang B, Hsu SH, Frankel W, Ghoshal K, Jacob ST, (2012) Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha. Hepatology 56: 186-197.
6. Chen M, Zhang J, Li N, Qian Z, Zhu M, et al. (2011) Promoter hypermethylation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancer. PLoS One 6: e25564.
7. Franco LM, Krishnamurthy V, Bali D, Weinstein DA, Arn P, et al. (2005) Hepatocellular carcinoma in glycogen storage disease type Ia: a case series. J Inherit Metab Dis 28: 153-162.
8. Labrune P, Trioche P, Duvaltier I, Chevalier P, Odievre M, (1997) Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr 24: 276-279.
9. Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, et al. (2002) Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr 161Suppl 1: S20-34.
10. Talente GM, Coleman RA, Alter C, Baker L, Brown BI, et al. (1994) Glycogen storage disease in adults. Ann Intern Med 120: 218-226.
11. Mutel E, Abdul-Wahed A, Ramamonjisoa N, Stefanutti A, Houberdon I, et al. (2011) Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas. J Hepatol 54: 529-537.
12. Bannasch P, Klimek F, Mayer D, (1997) Early bioenergetic changes in hepatocarcinogenesis: preneoplastic phenotypes mimic responses to insulin and thyroid hormone. J Bioenerg Biomembr 29: 303-313.
13. Altarejos JY, Montminy M, (2011) CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat Rev Mol Cell Biol 12: 141-151.
14. Lin HV, Accili D, (2011) Hormonal regulation of hepatic glucose production in health and disease. Cell Metab 14: 9-19.
15. Chakravarty K, Cassuto H, Reshef L, Hanson RW, (2005) Factors that control the tissue-specific transcription of the gene for phosphoenolpyruvate carboxykinase-C. Crit Rev Biochem Mol Biol 40: 129-154.
16. Roesler WJ, (2000) What is a cAMP response unit? Mol Cell Endocrinol 162: 1-7.
17. Vander Kooi BT, Onuma H, Oeser JK, Svitek CA, Allen SR, et al. (2005) The glucose-6-phosphatase catalytic subunit gene promoter contains both positive and negative glucocorticoid response elements. Mol Endocrinol 19: 3001-3022.
18. Lin B, Morris DW, Chou JY, (1997) The role of HNF1alpha, HNF3gamma, and cyclic AMP in glucose-6-phosphatase gene activation. Biochemistry 36: 14096-14106.
19. Hall RK, Wang XL, George L, Koch SR, Granner DK, (2007) Insulin represses phosphoenolpyruvate carboxykinase gene transcription by causing the rapid disruption of an active transcription complex: a potential epigenetic effect. Mol Endocrinol 21: 550-563.
20. Pan D, Mao C, Zou T, Yao AY, Cooper MP, et al. (2012) The histone demethylase Jhdm1a regulates hepatic gluconeogenesis. PLoS Genet 8: e1002761.
21. Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, et al. (2004) Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119: 941-953.
22. You A, Tong JK, Grozinger CM, Schreiber SL, (2001) CoREST is an integral component of the CoREST- human histone deacetylase complex. Proc Natl Acad Sci U S A 98: 1454-1458.
23. Shi Y, Sawada J, Sui G, Affar el B, Whetstine JR, et al. (2003) Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 422: 735-738.
24. Wang Y, Zhang H, Chen Y, Sun Y, Yang F, et al. (2009) LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. Cell 138: 660-672.
25. Harris WJ, Huang X, Lynch JT, Spencer GJ, Hitchin JR, et al. (2012) The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells. Cancer Cell 21: 473-487.
26. Whyte WA, Bilodeau S, Orlando DA, Hoke HA, Frampton GM, et al. (2012) Enhancer decommissioning by LSD1 during embryonic stem cell differentiation. Nature 482: 221-225.
27. Adamo A, Sese B, Boue S, Castano J, Paramonov I, et al. (2011) LSD1 regulates the balance between self-renewal and differentiation in human embryonic stem cells. Nat Cell Biol 13: 652-659.
28. Wang J, Hevi S, Kurash JK, Lei H, Gay F, et al. (2009) The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. Nat Genet 41: 125-129.
29. Wang J, Scully K, Zhu X, Cai L, Zhang J, et al. (2007) Opposing LSD1 complexes function in developmental gene activation and repression programmes. Nature 446: 882-887.
30. Schenk T, Chen WC, Gollner S, Howell L, Jin L, et al. (2012) Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia. Nat Med 18: 605-611.
31. Lee MG, Wynder C, Cooch N, Shiekhattar R, (2005) An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. Nature 437: 432-435.
32. Lee MG, Wynder C, Schmidt DM, McCafferty DG, Shiekhattar R, (2006) Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. Chem Biol 13: 563-567.
33. Schmidt DM, McCafferty DG, (2007) trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1. Biochemistry 46: 4408-4416.
34. Pei L, Waki H, Vaitheesvaran B, Wilpitz DC, Kurland IJ, et al. (2006) NR4A orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism. Nat Med 12: 1048-1055.
35. Chopra AR, Louet JF, Saha P, An J, Demayo F, et al. (2008) Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease. Science 322: 1395-1399.
36. Herzog B, Waltner-Law M, Scott DK, Eschrich K, Granner DK, (2000) Characterization of the human liver fructose-1,6-bisphosphatase gene promoter. Biochem J 351 Pt 2: 385-392.
37. Liu X, Wang X, Zhang J, Lam EK, Shin VY, et al. (2010) Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis. Oncogene 29: 442-450.
38. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, et al. (2007) High-resolution profiling of histone methylations in the human genome. Cell 129: 823-837.
39. Ciccone DN, Su H, Hevi S, Gay F, Lei H, et al. (2009) KDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints. Nature 461: 415-418.
40. Saijo K, Winner B, Carson CT, Collier JG, Boyer L, et al. (2009) A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 137: 47-59.
41. Lin J, Wu PH, Tarr PT, Lindenberg KS, St-Pierre J, et al. (2004) Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 119: 121-135.
42. Okamoto T, Kanemoto N, Ban T, Sudo T, Nagano K, et al. (2009) Establishment and characterization of a novel method for evaluating gluconeogenesis using hepatic cell lines, H4IIE and HepG2. Arch Biochem Biophys 491: 46-52.